rxstat › Shortages › Bacitracin Zinc Polymyxin B
Bacitracin Zinc Polymyxin B shortage status
No current shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Bacitracin Zinc Polymyxin B has no current shortage reported in Canada. It has been in shortage before; the history is below.
Reports by product
ResolvedPOLYDERM OINTMENT USP
500UNIT
10000UNIT · OINTMENT · TARO PHARMACEUTICALS INC
DIN 02181908 · ended Jan 6, 2026 · Disruption of the manufacture of the drug.
ResolvedPOLYDERM OINTMENT USP
500UNIT
10000UNIT · OINTMENT · TARO PHARMACEUTICALS INC
DIN 02181908 · ended Jan 6, 2026 · Disruption of the manufacture of the drug.
ResolvedPOLYDERM OINTMENT USP
500UNIT
10000UNIT · OINTMENT · TARO PHARMACEUTICALS INC
DIN 02181908 · ended Jun 26, 2025 · Disruption of the manufacture of the drug.
ResolvedPOLYDERM OINTMENT USP
10000UNIT
500UNIT · OINTMENT · TARO PHARMACEUTICALS INC
DIN 02181908 · ended Oct 27, 2023 · Disruption of the manufacture of the drug.
ResolvedPOLYDERM OINTMENT USP
500UNIT
10000UNIT · OINTMENT · TARO PHARMACEUTICALS INC
DIN 02181908 · ended Nov 5, 2020 · Disruption of the manufacture of the drug.
ResolvedPOLYDERM OINTMENT USP
500UNIT
10000UNIT · OINTMENT · TARO PHARMACEUTICALS INC
DIN 02181908 · ended Apr 13, 2020 · Disruption of the manufacture of the drug.
ResolvedPOLYDERM OINTMENT USP
500UNIT
10000UNIT · OINTMENT · TARO PHARMACEUTICALS INC
DIN 02181908 · ended Oct 4, 2019 · Disruption of the manufacture of the drug.
ResolvedPOLYDERM OINTMENT USP
500UNIT
10000UNIT · OINTMENT · TARO PHARMACEUTICALS INC
DIN 02181908 · ended Sep 20, 2019 · Disruption of the manufacture of the drug.
ResolvedPOLYDERM OINTMENT USP
500UNIT
10000UNIT · OINTMENT · TARO PHARMACEUTICALS INC
DIN 02181908 · ended Aug 15, 2019 · Disruption of the manufacture of the drug.
ResolvedPOLYDERM OINTMENT USP
500UNIT
10000UNIT · OINTMENT · TARO PHARMACEUTICALS INC
DIN 02181908 · ended Jun 14, 2019 · Disruption of the manufacture of the drug.
ResolvedPOLYDERM OINTMENT USP
500UNIT
10000UNIT · OINTMENT · TARO PHARMACEUTICALS INC
DIN 02181908 · ended Apr 18, 2019 · Disruption of the manufacture of the drug.
What's happening
There are no active shortage reports for Bacitracin Zinc Polymyxin B. Health Canada has 11 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Bacitracin Zinc Polymyxin B is classified under “ANTIBIOTICS FOR TOPICAL USE” (ATC D06AX).
Recent changes
Common questions
When will Bacitracin Zinc Polymyxin B be back in stock in Canada?
Bacitracin Zinc Polymyxin B has no active shortage; supply is normal per Health Canada reports.
Why is Bacitracin Zinc Polymyxin B in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.